After extensive and innovative research and a patent pending in 2020, Future Pharm is excited to announce the release of HEMPLETS™ Liposome Tablets.
What is HEMPLETS™?
HEMPLETS™ is the only liposomal chewable tablet in the world that has a patent pending liposome platform. It is designed to have an average particle distribution of 165 Nano meters, increases oral absorbance and bioavailability. HEMPLETS™ is designed to deliver a potent dose of CBD that is THC free in an oral tablet form unlike anything else. HEMPLETS™ is a highly advanced technology in a solid convenient chewable dosage form.
Why liposomal delivery in HEMPLETS™?
A liposome is a protective lipid layer that encapsulates CBD molecules by using liposomals as carriers. This led to the development of a completely new range of a CBD product that is patent pending. HEMPLETS™ liposomal CBD delivers products in chewable flavors that are unmatched in quality and scientifically proven while providing a fast and effective form of CBD supplementation.
What else makes HEMPLETS™ unique?
CBD is supplied in the USA by cGMP, FDA registered manufacturers using CO2 extraction. The solvent is considered a cleaner, purer form of extraction because there is no residue after extraction. HEMPLETS™ Liposome Chewable Tablets uses all-natural flavors and ingredients.
Future Pharm continues to bring high-quality supplements to market and we’re thrilled to announce the release of HEMPLETS™. As always, we appreciate the support of our customers who provided us valuable feedback which inspires every new product we create.